Active, Not Recruiting
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers
NCT02908906
- Conditions
- Neoplasms
- Locations
-
- St Louis, Missouri, United States
- Pittsburgh, Pennsylvania, United States
- Chisinau, Moldova
- Bialystok, Poland